Ischemic preconditioning protects against myocardial ischemia-reperfusion injury through inhibiting toll-like receptor 4/NF-κB signaling pathway in rats

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 10, 2011, Pages 972-978

  Yang, Jing ^a,b   Li, Yuanjian ^a   Hu, Changping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Heart; Ischemia reperfusion injury; Ischemic preconditioning; Rats; Toll like receptor 4

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TLR4 PROTEIN, RAT; TOLL LIKE RECEPTOR 4;

ANIMAL; ARTICLE; ISCHEMIC PRECONDITIONING; MALE; METABOLISM; METHODOLOGY; PHYSIOLOGY; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL REPERFUSION INJURY; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 82555193830     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.10.007     Document Type: Article

References (21)

1. Takeda K, Kaisho T, Akira S. Toll-like receptors [J]. Annu Rev Immunol, 2003, 21: 335-376. (Pubitemid 37174535)
2. Vallejo J G. Role of toll-like receptors in cardiovascular diseases [J]. Clin Sci (Lond), 2011, 121(1) :1-10.
3. Fang Y, Hu J. Toll-like receptor and its roles in myocardial ischemic/reperfusion injury [J]. Med Sei Monit, 2011, 17 (4): RA100-109.
4. Li C, Kao R L, Ha T, et al. Early activation of IKKβ during in vivo myocardial ischemia [J]. Am J Physiol Heart Circ Physiol, 2001, 280(3): H1264-1271.
5. Arslan F, de Kleijn D P, Pasterkamp G. Innate immune signaling in cardiac ischemia [J]. Nat Rev Cardiol, 2011, 8(5) : 292-300.
6. Oyama J, Biais C, Liu X, et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice [J]. Circulation, 2004, 109(6): 784-789. (Pubitemid 38222900)
7. Shimamoto A, Chong A J, Yada M, et al. Inhibition of Tolllike receptor 4 with eritoran attenuates myocardial ischemia/ reperfusion injury [J]. Circulation, 2006, 114(1 Suppl): 1270-274.
8. Ha T, Liu L, Kelley J, et al. Toll-like receptors: new players in myocardial ischemia/reperfusion injury [J]. Antioxid Redox Signal, 2011, 15(7); 1875-1893.
9. Cohen M V, Downey J M. Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice? [J]. J Cardiovasc Pharmacol Ther, 2011, 16(3/4): 273-280.
10. Chai W, Mehrotra S, Jan Danser A H, et al. The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts [J]. Eur J Pharmacol, 2006, 531(1-3): 246-253. (Pubitemid 43202242)
11. Wolfram S, Nienstedt J, Heidbreder M, et al. Calcitonin gene related peptide mediates cardioprotection by remote preconditioning [J]. Regul Pept, 2005, 127(1-3): 217-224. (Pubitemid 40179259)
12. Luo D, Deng P Y, Ye F, et al. Delayed preconditioning by cardiac ischemia involves endogenous calcitonin gene-related peptide via the nitric oxide pathway [J]. Eur J Pharmacol, 2004, 502(1/2): 135-141. (Pubitemid 39311374)
13. Li Y J, Peng J. The cardioprotection of calcitonin gene-related peptide-mediated preconditioning [J]. Eur J Pharmacol, 2002, 442(3) :173-177. (Pubitemid 34626191)
14. Harzenetter M D, Novotny A R, Gais P. Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER [J]. J Immunol, 2007, 179 (1): 607-615. (Pubitemid 46986578)
15. Zhang G, Ghosh S. Toll-Like receptor-mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity [J]. J Clin Invest, 2001, 107(1): 13-19. (Pubitemid 32047406)
16. ZeuKe S, Ulmer A J, Kusumoto S, et al. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS [J]. Cardiovas Res, 2002, 56(1) : 126-134.
17. Xu Z, Huang CX, Li Y, et al. Toll-like receptor 4 siRNA attenuates LPS-induced secretion of inflammatory cytokines and chemokines by macrophages [J]. J Infect, 2007, 55(1): el-9.
18. Frantz S, Tillmanns J, Kuhlencodt P J. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury [J]. Am J Pathol, 2007, 171 (2): 507-512. (Pubitemid 47344683)
19. Galaqudza M M, Blokhin I O, Shmonin A A, et al. Reduction of myocardial ischemia-reperfusion injury with pre- and postconditioning: molecular mechanisms and therapeutic targets [J]. Cardiovasc Hematol Disord Drug Targets, 2008, 8(1): 47-65.
20. Zaugg M, Schaub M C. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning [J]. J Muscle Res Cell Motil, 2003, 24(2/3) : 219-249. (Pubitemid 37323624)
21. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury [J]. Cardiovasc Res, 2004, 61 (3) : 481497.